Generics
Kaiser Permanente reports study findings showing significant cost savings
7 May 2026 - Health care provider Kaiser Permanente said on Wednesday that it has commissioned Milliman, a global actuarial and professional services consulting firm, to conduct a study comparing Kais...
Apotex receives Health Canada approval for a generic Ozempic equivalent
4 May 2026 - Apotex Inc, a Canada-based global health company, announced on Friday that Health Canada has approved Apo-Semaglutide InjectionTM, a generic equivalent of Ozempic (semaglutide injection)....
Cipla's AB-rated Ventolin HFA generic receives US FDA approval
24 April 2026 - Indian pharmaceutical company Cipla Limited (BSE:500087) (NSE:CIPLA-EQ) and its US subsidiary Cipla USA Inc announced on Thursday that the US Food and Drug Administration (FDA) has giv...
Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic
17 April 2026 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Friday that it has obtained Marketing Authorization in Denmark for Palbociclib Newbury tablets, mark...
Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval
13 April 2026 - Canadian pharmaceutical company Apotex Inc announced on Friday that its US subsidiary Apotex Corp has received the first US Food and Drug Administration (FDA) tentative approval for it...
DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules
10 April 2026 - DifGen Pharmaceuticals LLC, a US-based specialty generic pharmaceutical company, announced on Thursday that its Canadian partner, Apotex Inc, has received final approval from the US Fo...